We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Has The Personalized Psychiatry Market Size Shifted, And What Is the Outlook Through 2034?

The market size for personalized psychiatry has seen a swift expansion in recent times. It’s projected to escalate from $5.69 billion in 2024 to about $6.53 billion in 2025, with a compound annual growth rate (CAGR) of 14.8%. The growth witnessed during the historical period is due to heightened awareness of mental health, increasing incidence of psychiatric disorders, surging demand for tailored healthcare, increased healthcare spending, and improved accessibility and affordability of healthcare.

The market size of personalized psychiatry is anticipated to experience accelerated expansion in the forthcoming years, surging to $11.24 billion in 2029 at a 14.6% compound annual growth rate (CAGR). The projected growth is credited to a variety of factors including the increasing application of digital therapeutics, the growing necessity of remote patient tracking, higher demand for mental health solutions following the COVID-19 pandemic, greater investments in mental health by both the public and private sectors, and the requirement for more easily accessible mental healthcare solutions. Key trends during the forecast period encompass the improved application of artificial intelligence in mental health diagnosis, widespread acceptance of telepsychiatry and online consultations, along with the integration of blockchain for data security in mental health, augmented use of virtual reality (VR) for therapeutic interventions, and the proliferation of wearable devices for mental health tracking.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

What Are the Core Market Drivers Propelling Growth in the Personalized Psychiatry Industry?

Surging mental health problems are anticipated to spur the expansion of the personalized psychiatry market in the future. These challenges encompass a broad spectrum of conditions impacting an individual’s emotional, social, and psychological health. The escalation in mental health troubles can be attributed to the increase in stress and lifestyle-related obstacles, propelled by demanding work settings, inadequate work-life harmony, and scarce resilience strategies. Personalized psychiatry addresses these problems by providing customized treatment options that consider unique biological, psychological, and lifestyle influences. This targeted approach enhances the efficacy of care by minimizing guesswork in treatment strategies, thus enabling quicker recovery and better patient results. For example, in 2022, the National Institute of Mental Health, a research agency of the US federal government, estimated that 59.3 million adults aged 18 and up in the United States were suffering from any mental illness (AMI), making up 23.1% of the total adult population. Hence, the surge in mental health problems is fueling the expansion of the personalized psychiatry market.

How Is the Personalized Psychiatry Market Segmented?

The personalized psychiatry market covered in this report is segmented –

1) By Type: Products, Services, Software

2) By Technology: Genetic Testing, Artificial Intelligence, Neurostimulation Technology, Digital Therapeutics

3) By Application: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Attention-Deficit Hyperactivity Disorder (ADHD)

4) By End User: Clinics, Hospitals, Research Institutes, Homecare Settings

Subsegments:

1) By Products: Pharmacogenomic Test Kits, Wearable Devices, Brain Imaging Devices

2) By Services: Telepsychiatry, Personalized Treatment Planning, Behavioral Assessment

3) By Software: Clinical Decision Support Tools, Mental Health Apps, Virtual Therapy Platforms

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24365&type=smp

Which Regions Are Driving the Next Phase of the Personalized Psychiatry Market Growth?

North America was the largest region in the personalized psychiatry market in 2024. The regions covered in the personalized psychiatry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Personalized Psychiatry Industry?

In the personalized psychiatry market, key business players are concentrating their efforts on introducing advanced technology services such as bespoke telepsychiatry services. These are aimed at boosting access to personalized mental health care through a flexible, patient-centric service model. Personalized telepsychiatry services provide specialized psychiatric evaluation and treatment digitally, tailored to fit an individual’s unique genetic, environmental, and lifestyle factors. For instance, US-based psychiatry and wellness service company, Alice’s Psychiatry & Wellness, inaugurated a clinic in April 2025 that offers empathetic, customized psychiatric care to adults across different states via both face-to-face and telepsychiatry services. The clinic utilizes pharmacogenetic testing to individualize psychiatric medications according to each patient’s genetic makeup, thereby improving treatment efficacy and minimizing detrimental side effects. Through the use of digital platforms and continuous support from a dedicated provider, the clinic offers accessible, consistent, and inclusive mental health support, a reflection of the key principles of personalized psychiatry.

View the full report here:

https://www.thebusinessresearchcompany.com/report/personalized-psychiatry-global-market-report

How Is the Personalized Psychiatry Market Defined and What Are Its Core Parameters?

Personalized psychiatry is a tailored approach to mental health care that integrates genetic, biological, environmental, and clinical data to customize diagnosis, treatment planning, and therapeutic interventions for individual patients, aiming to improve outcomes and reduce trial-and-error prescribing. It is used to enhance treatment efficacy, minimize adverse effects, and facilitate early intervention by aligning psychiatric care with an individual patient’s unique biological and psychological profile.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24365&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model